| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.581 | 0.017 | 0.746 | Thioredoxin glutathione reductase inhibitor | 0.746 0.005 CID_96338 | CID_96338 | |
| 0.256 | 0.005 | 0.436 | Sphingosine 1-phosphate receptor 4 antagonist | 0.436 0.003 CID_96338 | CID_96338 | |
| 0.237 | 0.027 | 0.237 | Succinate dehydrogenase inhibitor | 0.235 0.028 CID_96338 | ||
| 0.212 | 0.004 | 0.212 | Sphingosine 1-phosphate receptor antagonist | 0.167 0.005 CID_96338 | ||
| 0.214 | 0.021 | 0.219 | Arachidonic acid antagonist | 0.219 0.018 CID_96338 | CID_96338 | |
| 0.243 | 0.053 | 0.374 | Anesthetic general | 0.374 0.02 CID_96338 | CID_96338 | |
| 0.175 | 0.015 | 0.175 | Folate antagonist | |||
| 0.134 | 0.043 | 0.17 | TRPA1 agonist | 0.17 0.02 CID_96338 | CID_96338 | |
| 0.099 | 0.009 | 0.103 | Sphingosine 1-phosphate receptor 1 antagonist | 0.103 0.009 CID_96338 | CID_96338 | |
| 0.11 | 0.038 | 0.142 | Thioredoxin inhibitor | 0.142 0.02 CID_96338 | CID_96338 | |
| 0.087 | 0.016 | 0.087 | Nitric oxide donor | |||
| 0.124 | 0.065 | 0.124 | Alkylator | 0.124 0.064 CID_96338 | ||
| 0.106 | 0.049 | 0.112 | Electrolyte absorption antagonist | 0.112 0.044 CID_96338 | CID_96338 | |
| 0.209 | 0.154 | 0.258 | Thyroid hormone antagonist | 0.258 0.118 CID_96338 | CID_96338 | |
| 0.184 | 0.13 | 0.316 | DNA damaging | 0.316 0.051 CID_96338 | CID_96338 | |
| 0.093 | 0.044 | 0.18 | Glutathione S-transferase inhibitor | 0.18 0.007 CID_96338 | CID_96338 | |
| 0.256 | 0.208 | 0.357 | Apoptosis agonist | 0.357 0.135 CID_96338 | CID_96338 | |
| 0.149 | 0.102 | 0.32 | 3C-like protease (Human coronavirus) inhibitor | 0.32 0.008 CID_96338 | CID_96338 | |
| 0.084 | 0.042 | 0.333 | Telomerase inhibitor | 0.333 0.005 CID_96338 | CID_96338 | |
| 0.121 | 0.084 | 0.121 | Vanilloid 1 agonist | |||
| 0.033 | 0.01 | 0.033 | DNA polymerase III inhibitor | 0.033 0.011 CID_96338 | ||
| 0.141 | 0.119 | 0.141 | Lipocortins synthesis antagonist | |||
| 0.028 | 0.012 | 0.032 | Acid ceramidase inhibitor | 0.032 0.008 CID_96338 | CID_96338 | |
| 0.051 | 0.035 | 0.051 | CXC chemokine 1 receptor antagonist | |||
| 0.014 | 0.006 | 0.015 | DNA polymerase III polC-type inhibitor | 0.015 0.005 CID_96338 | CID_96338 | |
| 0.089 | 0.085 | 0.596 | Cyclin-dependent kinase 5 inhibitor | 0.596 0.004 CID_96338 | CID_96338 | |
| 0.12 | 0.117 | 0.12 | Phospholipase A2 inhibitor | |||
| 0.162 | 0.16 | 0.269 | Calpain inhibitor | 0.269 0.049 CID_96338 | CID_96338 | |
| 0.083 | 0.082 | 0.083 | Sphingomyelinase inhibitor | |||
| 0.1 | 0.103 | 0.16 | Cyclooxygenase 3 inhibitor | 0.16 0.04 CID_96338 | CID_96338 | |
| 0.077 | 0.081 | 0.146 | Triose-phosphate isomerase inhibitor | 0.146 0.021 CID_96338 | CID_96338 | |
| 0.01 | 0.014 | 0.021 | Melatonin 2 antagonist | 0.021 0.004 CID_96338 | CID_96338 | |
| 0.077 | 0.086 | 0.156 | Aminopeptidase B inhibitor | 0.156 0.035 CID_96338 | CID_96338 | |
| 0.164 | 0.178 | 0.221 | DNA synthesis inhibitor | 0.221 0.093 CID_96338 | CID_96338 | |
| 0.065 | 0.085 | 0.078 | Ornithine decarboxylase inhibitor | 0.078 0.069 CID_96338 | CID_96338 | |
| 0.029 | 0.05 | 0.045 | Membrane dipeptidase inhibitor | 0.045 0.02 CID_96338 | CID_96338 | |
| 0.045 | 0.069 | 0.085 | Sphingosine 1-phosphate receptor 3 antagonist | 0.085 0.014 CID_96338 | CID_96338 | |
| 0.078 | 0.102 | 0.107 | Anabolic | 0.107 0.053 CID_96338 | CID_96338 | |
| 0.071 | 0.096 | 0.09 | Thioredoxin reductase inhibitor | 0.09 0.041 CID_96338 | CID_96338 | |
| 0.13 | 0.16 | 0.174 | Neurotensin receptor agonist | 0.174 0.057 CID_96338 | CID_96338 | |
| 0.092 | 0.124 | 0.166 | Cathepsin H inhibitor | 0.166 0.036 CID_96338 | CID_96338 | |
| 0.078 | 0.112 | 0.15 | Anesthetic local | 0.15 0.049 CID_96338 | CID_96338 | |
| 0.008 | 0.042 | 0.024 | Melatonin receptor 1A antagonist | 0.024 0.005 CID_96338 | CID_96338 | |
| 0.052 | 0.087 | 0.109 | Aminopeptidase I inhibitor | 0.109 0.024 CID_96338 | CID_96338 | |
| 0.037 | 0.074 | 0.187 | Acetyl-CoA transferase inhibitor | 0.187 0.005 CID_96338 | CID_96338 | |
| 0.158 | 0.196 | 0.235 | Thyroid hormone beta antagonist | 0.235 0.128 CID_96338 | CID_96338 | |
| 0.04 | 0.08 | 0.12 | Androgen agonist | 0.12 0.01 CID_96338 | CID_96338 | |
| 0.019 | 0.061 | 0.04 | Melatonin agonist | 0.04 0.015 CID_96338 | CID_96338 | |
| 0.009 | 0.052 | 0.03 | Melatonin 1 antagonist | 0.03 0.007 CID_96338 | CID_96338 | |
| 0.027 | 0.071 | 0.087 | Acetyl-CoA transferase 1 inhibitor | 0.087 0.005 CID_96338 | CID_96338 | |
| 0.068 | 0.116 | 0.152 | UDP-glucose 4-epimerase inhibitor | 0.152 0.028 CID_96338 | CID_96338 | |
| 0.122 | 0.171 | 0.129 | Ca2+-transporting ATPase inhibitor | 0.129 0.126 CID_96338 | CID_96338 | |
| 0.169 | 0.221 | 0.448 | Calpain 2 inhibitor | 0.448 0.04 CID_96338 | CID_96338 | |
| 0.028 | 0.082 | 0.043 | Dihydrofolate reductase inhibitor | 0.043 0.032 CID_96338 | CID_96338 | |
| 0.034 | 0.094 | 0.07 | Carbamoyl phosphate synthetase inhibitor | 0.07 0.034 CID_96338 | CID_96338 | |
| 0.011 | 0.072 | 0.045 | Melatonin antagonist | 0.045 0.009 CID_96338 | CID_96338 | |
| 0.014 | 0.08 | 0.071 | Nicotinic acid receptor agonist | 0.071 0.008 CID_96338 | CID_96338 | |
| 0.044 | 0.11 | 0.073 | Cathepsin G inhibitor | 0.073 0.05 CID_96338 | CID_96338 | |
| 0.048 | 0.121 | 0.171 | GABA aminotransferase inhibitor | 0.171 0.005 CID_96338 | CID_96338 | |
| 0.157 | 0.235 | 0.252 | Tyrosine 3 hydroxylase inhibitor | 0.252 0.066 CID_96338 | CID_96338 | |
| 0.156 | 0.242 | 0.201 | Antithrombotic | 0.201 0.176 CID_96338 | CID_96338 | |
| 0.055 | 0.145 | 0.11 | Prolactin inhibitor | 0.11 0.046 CID_96338 | CID_96338 | |
| 0.004 | 0.095 | 0.016 | Ileal bile acid transport inhibitor | 0.016 0.014 CID_96338 | CID_96338 | |
| 0.069 | 0.16 | 0.136 | Caspase 3 inhibitor | 0.136 0.04 CID_96338 | CID_96338 | |
| 0.051 | 0.147 | 0.101 | Alcohol dehydrogenase inhibitor | 0.101 0.051 CID_96338 | CID_96338 | |
| 0.166 | 0.262 | 0.326 | Transcription factor inhibitor | 0.326 0.141 CID_96338 | CID_96338 | |
| 0.05 | 0.148 | 0.073 | Chymotrypsin inhibitor | 0.073 0.065 CID_96338 | CID_96338 | |
| 0.095 | 0.194 | 0.179 | GABA C receptor rho-2 antagonist | 0.179 0.043 CID_96338 | CID_96338 | |
| 0.067 | 0.167 | 0.104 | Microtubule formation inhibitor | 0.104 0.084 CID_96338 | CID_96338 | |
| 0.011 | 0.117 | 0.029 | Nicotinic acid receptor 2 antagonist | 0.029 0.014 CID_96338 | CID_96338 | |
| 0.042 | 0.149 | 0.087 | Glutamate dehydrogenase inhibitor | 0.087 0.039 CID_96338 | CID_96338 | |
| 0.006 | 0.118 | 0.102 | NMDA receptor glycine site antagonist | 0.102 0.004 CID_96338 | CID_96338 | |
| 0.142 | 0.254 | 0.253 | Vasodilator, coronary | 0.253 0.131 CID_96338 | CID_96338 | |
| 0.116 | 0.23 | 0.179 | Cyclic AMP phosphodiesterase inhibitor | 0.179 0.112 CID_96338 | CID_96338 | |
| 0.065 | 0.181 | 0.225 | Alpha-N-acetylglucosaminidase inhibitor | 0.225 0.028 CID_96338 | CID_96338 | |
| 0.002 | 0.134 | 0.009 | DNA topoisomerase III inhibitor | 0.009 0.004 CID_96338 | CID_96338 | |
| 0.024 | 0.164 | 0.049 | Glucagon-like peptide 1 receptor antagonist | 0.049 0.014 CID_96338 | CID_96338 | |
| 0.054 | 0.198 | 0.13 | Proteasome inhibitor | 0.13 0.058 CID_96338 | CID_96338 | |
| 0.033 | 0.176 | 0.214 | Androgen antagonist | 0.214 0.012 CID_96338 | CID_96338 | |
| 0.047 | 0.195 | 0.212 | Ferrochelatase inhibitor | 0.212 0.02 CID_96338 | CID_96338 | |
| 0.183 | 0.339 | 0.352 | 5 Hydroxytryptamine release inhibitor | 0.352 0.113 CID_96338 | CID_96338 | |
| 0.143 | 0.302 | 0.302 | GABA C receptor rho-3 antagonist | 0.302 0.115 CID_96338 | CID_96338 | |
| 0.076 | 0.238 | 0.12 | Thiol protease inhibitor | 0.12 0.118 CID_96338 | CID_96338 | |
| 0.014 | 0.177 | 0.055 | Fructose-1,6-bisphosphatase inhibitor | 0.055 0.02 CID_96338 | CID_96338 | |
| 0.049 | 0.214 | 0.115 | GABA C receptor rho-1 antagonist | 0.115 0.044 CID_96338 | CID_96338 | |
| 0.035 | 0.201 | 0.081 | Glycine receptor antagonist | 0.081 0.055 CID_96338 | CID_96338 | |
| 0.028 | 0.196 | 0.078 | Sodium/calcium exchanger inhibitor | 0.078 0.009 CID_96338 | CID_96338 | |
| 0.089 | 0.257 | 0.143 | Sphingosine 1-phosphate receptor 5 antagonist | 0.143 0.074 CID_96338 | CID_96338 | |
| 0.048 | 0.219 | 0.118 | GABA C receptor antagonist | 0.118 0.054 CID_96338 | CID_96338 | |
| 0.118 | 0.295 | 0.168 | RNA-directed DNA polymerase inhibitor | 0.168 0.156 CID_96338 | CID_96338 | |
| 0.174 | 0.365 | 0.256 | Caspase 9 stimulant | 0.256 0.246 CID_96338 | CID_96338 | |
| 0.041 | 0.232 | 0.115 | Cystathionine beta-synthase inhibitor | 0.115 0.062 CID_96338 | CID_96338 | |
| 0.03 | 0.23 | 0.075 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.075 0.048 CID_96338 | CID_96338 | |
| 0.085 | 0.289 | 0.184 | Neurotrophic factor enhancer | 0.184 0.094 CID_96338 | CID_96338 | |
| 0.072 | 0.278 | 0.116 | Sphingosine 1-phosphate receptor 2 antagonist | 0.116 0.106 CID_96338 | CID_96338 | |
| 0.137 | 0.347 | 0.237 | 5 Hydroxytryptamine uptake stimulant | 0.237 0.094 CID_96338 | CID_96338 | |
| 0.05 | 0.269 | 0.131 | mTOR complex 1 inhibitor | 0.131 0.019 CID_96338 | CID_96338 | |
| 0.039 | 0.263 | 0.101 | Phosphodiesterase I inhibitor | 0.101 0.043 CID_96338 | CID_96338 | |
| 0.122 | 0.354 | 0.211 | Histamine release inhibitor | 0.211 0.189 CID_96338 | CID_96338 | |
| 0.098 | 0.339 | 0.205 | Immunosuppressant | 0.205 0.192 CID_96338 | CID_96338 | |
| 0.01 | 0.253 | 0.055 | Delayed rectifier potassium channel activator | 0.055 0.013 CID_96338 | CID_96338 | |
| 0.01 | 0.253 | 0.055 | Potassium channel KCNQ activator | 0.055 0.013 CID_96338 | CID_96338 | |
| 0.123 | 0.38 | 0.204 | Interleukin 2 agonist | 0.204 0.182 CID_96338 | CID_96338 | |
| 0.121 | 0.389 | 0.192 | 5 Hydroxytryptamine 3E antagonist | 0.192 0.077 CID_96338 | CID_96338 | |
| 0.018 | 0.289 | 0.14 | NMDA receptor antagonist | 0.14 0.027 CID_96338 | CID_96338 | |
| 0.009 | 0.282 | 0.062 | CDK5/p25 inhibitor | 0.062 0.014 CID_96338 | CID_96338 | |
| 0.016 | 0.292 | 0.04 | Potassium channel Kv1.1 blocker | 0.04 0.023 CID_96338 | CID_96338 | |
| 0.054 | 0.334 | 0.203 | Hypolipemic | 0.203 0.092 CID_96338 | CID_96338 | |
| 0.005 | 0.289 | 0.027 | Cyclin E2 inhibitor | 0.027 0.022 CID_96338 | CID_96338 | |
| 0.035 | 0.325 | 0.089 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.089 0.067 CID_96338 | CID_96338 | |
| 0.02 | 0.323 | 0.071 | Bombesin 1 receptor agonist | 0.071 0.03 CID_96338 | CID_96338 | |
| 0.077 | 0.388 | 0.181 | Histone acetyltransferase inhibitor | 0.181 0.097 CID_96338 | CID_96338 | |
| 0.074 | 0.393 | 0.392 | DNA directed DNA polymerase inhibitor | 0.392 0.119 CID_96338 | CID_96338 | |
| 0.024 | 0.352 | 0.13 | Potassium channel (Voltage-sensitive) activator | 0.13 0.024 CID_96338 | CID_96338 | |
| 0.02 | 0.372 | 0.072 | Dihydroorotate oxidase inhibitor | 0.072 0.016 CID_96338 | CID_96338 | |
| 0.008 | 0.382 | 0.059 | NMDA receptor glycine site agonist | 0.059 0.047 CID_96338 | CID_96338 | |
| 0.042 | 0.416 | 0.185 | Prostaglandin dehydrogenase inhibitor | 0.185 0.168 CID_96338 | CID_96338 | |
| 0.023 | 0.406 | 0.096 | GABA C receptor agonist | 0.096 0.071 CID_96338 | CID_96338 | |
| 0.093 | 0.482 | 0.203 | Nitric-oxide synthase stimulant | 0.203 0.084 CID_96338 | CID_96338 | |
| 0.038 | 0.435 | 0.212 | Beta lactamase inhibitor | 0.212 0.177 CID_96338 | CID_96338 | |
| 0.034 | 0.436 | 0.139 | NADPH oxidase inhibitor | 0.139 0.063 CID_96338 | CID_96338 | |
| 0.065 | 0.472 | 0.21 | Gastrin inhibitor | 0.21 0.134 CID_96338 | CID_96338 | |
| 0.016 | 0.442 | 0.09 | Urease inhibitor | 0.09 0.079 CID_96338 | CID_96338 | |
| 0.024 | 0.503 | 0.193 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.193 0.104 CID_96338 | CID_96338 | |
| 0.03 | 0.515 | 0.126 | Neuropeptide Y1 antagonist | 0.126 0.109 CID_96338 | CID_96338 | |
| 0.116 | 0.604 | 0.346 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.346 0.155 CID_96338 | CID_96338 | |
| 0.011 | 0.509 | 0.091 | MAP3K7 inhibitor | 0.091 0.028 CID_96338 | CID_96338 | |
| 0.037 | 0.541 | 0.162 | ATPase inhibitor | 0.162 0.082 CID_96338 | CID_96338 | |
| 0.009 | 0.516 | 0.079 | CDK2/cyclin E2 inhibitor | 0.079 0.039 CID_96338 | CID_96338 | |
| 0.029 | 0.544 | 0.371 | DNA polymerase beta inhibitor | 0.371 0.131 CID_96338 | CID_96338 | |
| 0.099 | 0.625 | 0.51 | Calcium channel L-type activator | 0.51 0.024 CID_96338 | CID_96338 | |
| 0.03 | 0.57 | 0.129 | Antipruritic | 0.129 0.124 CID_96338 | CID_96338 | |
| 0.035 | 0.58 | 0.295 | Hypoxia-inducible factor 1 alpha inhibitor | 0.295 0.068 CID_96338 | CID_96338 | |
| 0.011 | 0.575 | 0.167 | Cyclin-dependent kinase inhibitor | 0.167 0.049 CID_96338 | CID_96338 | |
| 0.058 | 0.623 | 0.206 | Calcium channel activator | 0.206 0.205 CID_96338 | CID_96338 | |
| 0.035 | 0.607 | 0.176 | Neuropeptide Y2 antagonist | 0.176 0.169 CID_96338 | CID_96338 | |
| 0.007 | 0.679 | 0.085 | Potassium channel activator | 0.085 0.067 CID_96338 | CID_96338 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |